FORT MYERS, Fla. (AP) — FORT MYERS, Fla. (AP) — NeoGenomics Inc. (NEO) on Tuesday reported a loss of $27.1 million in its third quarter.
On a per-share basis, the Fort Myers, Florida-based company said it had a loss of 21 cents. Earnings, adjusted for stock option expense and amortization costs, came to 3 cents per share.
The results surpassed Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for earnings of 2 cents per share.
The operator of cancer-focused testing laboratories posted revenue of $187.8 million in the period, which also beat Street forecasts. Six analysts surveyed by Zacks expected $183.6 million.
NeoGenomics expects full-year earnings in the range of 8 cents to 12 cents per share.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on NEO at https://www.zacks.com/ap/NEO
Copyright © 2025 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
